Associate Professor Coral Gartner

Associate Professor

School of Public Health
Faculty of Medicine
c.gartner@uq.edu.au
+61 7 334 65478

Overview

Associate professor Coral Gartner’s is an international expert in tobacco control policy. She is the Director of the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), and a Co-Investigator with the International Tobacco Control Policy Evaluation Project (ITC Project), the SewAUs Wastewater Epidemiology Project, and with the International Consortium for the Population Impact of Electronic CigarEttes (IC-PIECE). She is currently the Deputy Chair of the School of Public Health’s Research Committee, the Regional Editor for Australasia for the BMJ journal, Tobacco Control, after serving as a senior editor from 2012-2018. She is currently the President Elect of the Oceania Chapter of the Society for Research on Nicotine and Tobacco (SRNT-O), and is a member of the Australian Academic of Health and Medical Sciences’ (AAHMS) Policy Committee.

She leads a multidisciplinary research team of international experts located in Australia, New Zealand, and Canada, to develop the evidence base for tobacco endgame strategies and to identify the most promising policies that could end the cigarette epidemic in Australia, and beyond. Her research program includes consideration of how these policies could be implemented, while mitigating potential unintended impacts and increasing equity. Her research methods span cohort studies, clinical trials, policy analyses, simulation modelling and mixed methods research.

Associate Professor Gartner joined the University of Queensland in 2006. With undergraduate qualifications in environmental health and a PhD in environmental epidemiology, she completed a postdoctoral fellowship on tobacco control policy and held a NHMRC Career Development Fellowship (2014-2018). In 2019, she led the development of UQ’s flagship cross-faculty postgraduate programs in Environmental Health Sciences.

Associate Professor Gartner has published over 200 academic works, including journal articles, book chapters, and submissions to government inquiries, and has served as an expert witness to a number of government inquiries and consulations. She has also authored articles on tobacco control topics for The Conversation.

Qualifications

  • Doctor of Philosophy, Queensland University of Technology
  • Bachelor of Applied Science - Environmental Health, Queensland University of Technology
  • Bachelor of Health Sciences (Honours), Queensland University of Technology

Publications

View all Publications

Supervision

  • Doctor Philosophy

  • Doctor Philosophy

  • Doctor Philosophy

View all Supervision

Available Projects

  • Tobacco smoking is the leading cause of preventable death globally, killing over 7 million people per year. In Australia, smoking causes 20,933 deaths per year, accounting for nearly 1 in 7 deaths and 9% of disease burden. Discussion is growing about how to end the cigarette epidemic, meaning reducing smoking prevalence to a level that is no longer a major public health issue. Once seen as ‘unthinkable’, this goal is now part of mainstream tobacco control research and government health policy. A range of endgame strategies have been proposed; some have been implemented or are under serious consideration in other countries. The NHMRC-funded Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE) will develop the evidence base for and outline a roadmap for Australia to end smoking in Australia. The Tobacco Endgame CRE has two remaining earmarked scholarships available with a possible additional $5,000 per annum top up scholarship available for exceptional canddiates.

    Multiple PhD projects are available covering the topics listed below.

    1. Estimating the impact of proposed endgame strategies on smoking prevalence, particularly for priority groups

    2. Identifying the legal barriers and enablers, likely legal challenges and potential defences, of tobacco endgame strategies

    3. Determining policy maker and public support, including among priority groups, for tobacco endgame strategies

    4. Optimising public communications about tobacco endgame strategies to inform and generate discussion

    5. Identifying potential unintended impacts and developing appropriate mitigation strategies (including optimising smoking cessation for priority groups, and understanding the impact on the illicit tobacco market)

    6. The economics of ending tobacco sales in Australia

    Preferred educational background: Undergraduate Class I or IIA honours or Masters degree in Public Health, Health Sciences, Chemistry, Behavioural Sciences, Biostatistics, Epidemiology, Environmental Health, Regulatory Science, Health Law, Health Policy, Political Science, Business, Economics, Communications, Psychology or a related field. Knowledge and experience in health policy or product regulation would be highly valued.

    If you are interested in one of these topics, please contact Associate Professor Gartner to discuss. Aboriginal and Torres Strait Islander candidates are especially encouraged to apply.

  • Australia's regulatory policy on nicotine vaping products (e-cigarettes) is unique in the world. Modelled on the current program that allows access to medicinal cannabis products, from 1 October 2021, Australians can access nicotine vaping products that have been prescribed to them by a medical practitioner and are supplied via one of three pathways for accessing unapproved therapeutic goods. The regulation is intended to allow people who smoke to access these products as smoking cessation aids while protecting youth from taking up vaping. This HDR project will evaluate Australia's unique regulatory approach and draw conclusions that will assist other countries who may be looking for possible regulatory models for nicotine vaping products.

  • Smoking prevalence in the general Australian population is among the lowest of any high income country. However, it still remains a highly prevalent source of exposure to toxic chemical exposure in the Australian population. In most countries, including Australia, the design and construction of tobacco cigarettes remains relatively unregulated.

    Article 9 of the World Health Organization’s Framework Convention on Tobacco Control requires parties to the treaty to regulate the contents and emissions of tobacco products. Hence, there have been increasing moves internationally to develop product standards for cigarettes with the aims of reducing the attractiveness and palatability of cigarettes or reducing exposure to harmful and potentially harmful chemicals in tobacco smoke. There has also been a growing interest in banning filters from cigarettes due to their environmental impact. New nicotine products, such as e-cigarettes and other vaporisers and heated tobacco products are creating further new challenges for regulators in determining appropriate product standards. This PhD will develop the evidence base for development of effective regulation of nicotine and tobacco products to assist with the implementation of Article 9 of the WHO FCTC.

    Preferred educational background: Undergraduate Class I or IIA honours or Masters degree in Public Health, Health Sciences, Chemistry, Behavioural Sciences, Biostatistics, Environmental Health, Regulatory Science, Health Law, Health Policy or a related field. Knowledge and experience in health policy or product regulation would be highly valued.

View all Available Projects

Publications

Book Chapter

  • Gartner, Coral and Hall, Wayne (2020). Lessons from tobacco regulation for cannabis product regulation. Legalizing cannabis. (pp. 233-258) edited by Tom Decorte, Simon Lenton and Chris Wilkins. Abingdon, Oxon, United Kingdom: Routledge. doi: 10.4324/9780429427794-14

  • Gartner, Coral and Bromberg, Marilyn (2019). One does not simply sell e-cigarettes in Australia: an overview of Australian e-cigarette regulations. The regulation of e-cigarettes: international, European and national challenges. (pp. 249-279) edited by Lukasz Gruszczynski. Cheltenham, United Kingdom: Edward Elgar Publishing.

  • Gartner, Coral (2019). One does not simply sell e-cigarettes in Australia: an overview of Australian e-cigarette regulations. The Regulation of E-cigarettes. (pp. 249-278) Cheltenham, United Kingdom: Edward Elgar Publishing. doi: 10.4337/9781788970464.00021

  • Hall, W., Gartner, C. and Vittiglia, A. (2018). Smokers’ attitudes to and beliefs about addiction. Tobacco in Australia: Facts and issues. (pp. 6.14-6.14) edited by Scollo, M. and Winstanley, M.. Melbourne, VIC Australia: Cancer Council Victoria.

  • Degenhardt, Louisa, Gartner, Coral and Hall, Wayne D. (2015). The epidemiology of tobacco, alcohol, and illicit drug use and their contribution to the burden of disease. Addiction medicine: principles and practice. (pp. 8-21) edited by Paul Haber, Carolyn Day and Michael Farrell. Sydney, Australia: IP Communications.

  • Gartner, Coral E. and Partridge, Brad (2012). Addiction neuroscience and tobacco control. Addiction neuroethics: The ethics of addiction neuroscience research and treatment. (pp. 75-93) edited by Adrian Carter, Wayne Hall and Judy Illes. New York, NY, United States: Elsevier. doi: 10.1016/B978-0-12-385973-0.00004-1

  • Gartner, Coral (2012). Smokeless tobacco and harm reduction. Tobacco in Australia: facts and issues. (pp. 39-41) Melbourne, Australia: Cancer Council Victoria.

  • Hall, Wayne D., Gartner, Coral E., Mathews, Rebecca and Munafo, Marcus (2012). Technical, ethical and social issues in the bioprediction of addiction liability and treatment response. Addiction neuroethics: the ethics of addiction neuroscience research and treatment. (pp. 115-135) edited by Adrian Carter, Wayne Hall and Judy Illes. New York, NY, United States: Academic Press. doi: 10.1016/B978-0-12-385973-0.00006-5

  • Gartner, Coral and Hall, Wayne (2011). Challenges in reducing the disease burden of tobacco smoking. Substance abuse disorders: Evidence and experience. (pp. 275-281) edited by Hamid Ghodse, Helen Herrman, Mario Maj and Norman Sartorius. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1002/9780470975084.ch22

  • Gartner Coral, Hall, Wayne and McNeill, Ann (2010). Harm reduction policies for tobacco. Harm reduction: evidence, impacts and challenges. (pp. 279-300) edited by Tim Rhodes and Dagmar Hedrich. Luxembourg: Office for Official Publications of the European Communities.

  • Gartner, C. E. (2008). Smokeless tobacco and harm reduction. Tobacco in Australia: Facts and issues: A comprehensive online resource. (pp. 39-41) edited by M. H. Winstanley and M. M. Scollo. Melbourne, Vic., Australia: Cancer Council Victoria.

Journal Article

Conference Publication

Other Outputs

Grants (Administered at UQ)

PhD and MPhil Supervision

Current Supervision

Completed Supervision

Possible Research Projects

Note for students: The possible research projects listed on this page may not be comprehensive or up to date. Always feel free to contact the staff for more information, and also with your own research ideas.

  • Tobacco smoking is the leading cause of preventable death globally, killing over 7 million people per year. In Australia, smoking causes 20,933 deaths per year, accounting for nearly 1 in 7 deaths and 9% of disease burden. Discussion is growing about how to end the cigarette epidemic, meaning reducing smoking prevalence to a level that is no longer a major public health issue. Once seen as ‘unthinkable’, this goal is now part of mainstream tobacco control research and government health policy. A range of endgame strategies have been proposed; some have been implemented or are under serious consideration in other countries. The NHMRC-funded Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE) will develop the evidence base for and outline a roadmap for Australia to end smoking in Australia. The Tobacco Endgame CRE has two remaining earmarked scholarships available with a possible additional $5,000 per annum top up scholarship available for exceptional canddiates.

    Multiple PhD projects are available covering the topics listed below.

    1. Estimating the impact of proposed endgame strategies on smoking prevalence, particularly for priority groups

    2. Identifying the legal barriers and enablers, likely legal challenges and potential defences, of tobacco endgame strategies

    3. Determining policy maker and public support, including among priority groups, for tobacco endgame strategies

    4. Optimising public communications about tobacco endgame strategies to inform and generate discussion

    5. Identifying potential unintended impacts and developing appropriate mitigation strategies (including optimising smoking cessation for priority groups, and understanding the impact on the illicit tobacco market)

    6. The economics of ending tobacco sales in Australia

    Preferred educational background: Undergraduate Class I or IIA honours or Masters degree in Public Health, Health Sciences, Chemistry, Behavioural Sciences, Biostatistics, Epidemiology, Environmental Health, Regulatory Science, Health Law, Health Policy, Political Science, Business, Economics, Communications, Psychology or a related field. Knowledge and experience in health policy or product regulation would be highly valued.

    If you are interested in one of these topics, please contact Associate Professor Gartner to discuss. Aboriginal and Torres Strait Islander candidates are especially encouraged to apply.

  • Australia's regulatory policy on nicotine vaping products (e-cigarettes) is unique in the world. Modelled on the current program that allows access to medicinal cannabis products, from 1 October 2021, Australians can access nicotine vaping products that have been prescribed to them by a medical practitioner and are supplied via one of three pathways for accessing unapproved therapeutic goods. The regulation is intended to allow people who smoke to access these products as smoking cessation aids while protecting youth from taking up vaping. This HDR project will evaluate Australia's unique regulatory approach and draw conclusions that will assist other countries who may be looking for possible regulatory models for nicotine vaping products.

  • Smoking prevalence in the general Australian population is among the lowest of any high income country. However, it still remains a highly prevalent source of exposure to toxic chemical exposure in the Australian population. In most countries, including Australia, the design and construction of tobacco cigarettes remains relatively unregulated.

    Article 9 of the World Health Organization’s Framework Convention on Tobacco Control requires parties to the treaty to regulate the contents and emissions of tobacco products. Hence, there have been increasing moves internationally to develop product standards for cigarettes with the aims of reducing the attractiveness and palatability of cigarettes or reducing exposure to harmful and potentially harmful chemicals in tobacco smoke. There has also been a growing interest in banning filters from cigarettes due to their environmental impact. New nicotine products, such as e-cigarettes and other vaporisers and heated tobacco products are creating further new challenges for regulators in determining appropriate product standards. This PhD will develop the evidence base for development of effective regulation of nicotine and tobacco products to assist with the implementation of Article 9 of the WHO FCTC.

    Preferred educational background: Undergraduate Class I or IIA honours or Masters degree in Public Health, Health Sciences, Chemistry, Behavioural Sciences, Biostatistics, Environmental Health, Regulatory Science, Health Law, Health Policy or a related field. Knowledge and experience in health policy or product regulation would be highly valued.

  • The vast majority of people who smoke started when they were teenagers and did not fully appreciate the addictiveness and health risk of smoking. Research shows that around 90% of people who smoke regret having started and the majority would like to stop smoking. Continued smoking is influenced by both commercial and social factors that can create an environment that reduces people's ability to quit smoking. For example, the addictiveness of cigarettes, and their widespread availability, make stopping smoking very difficult for many people. However, people who develop a tobacco-related disease often feel a sense of shame, and self-blame. Lung cancer has become a stigmatised health condition, with people with this condition sometimes unfairly viewed as having caused their own illness. Such victim-blaming attitudes provides cover to the tobacco industry who are the source of the problem of smoking, and discourages people with a tobacco-related disease and their families from being vocal advocates for new tobacco control policies that would support people who smoke to quit or to not take up smoking. This research project will examine and test ways to overcome tobacco-related stigma to empower people impacted by tobacco to become advocates for tobacco control policy. It will draw lessons from other examples such as the history of HIV/AIDS activism.